APIM050057: PCI-27483
CAS No.: 871266-63-6.
Purity: 99.5% (HPLC at 254 nm).
QC: HPLC, 1HNMR and Quantitative Elemental Analysis.
Solubility: Soluble in DMSO.BP001902-PRO-331: Recombinant Human Coagulation Factor VIIa (FVIIa) Protein
Source: BHK cells-derived.
The potency per mg of recombinant human FVIIa protein was tested and found to be 50,000 Units/mg.
Purity: > 98.0% as determined by (a) Analysis by RP-HPLC; (b) Analysis by SDS-PAGE.C016: NovoSeven Biosimilar Stable Cell Line (CHO)
The yield of NovoSeven biosimilar from the CHO stable cell line was above 30 mg/L in a 1000 liter manufacturing.
C016: NovoSeven Biosimilar Stable Cell Line (CHO)
The yield of NovoSeven biosimilar from the CHO stable cell line was above 30 mg/L in a 1000 liter manufacturing.
APIM050267: PCI-27483
CAS No.: 871266-63-6.
Purity: 99.5% (HPLC at 254 nm).
QC: HPLC, 1HNMR and Quantitative Elemental Analysis.
Solubility: Soluble in DMSO.C042P: Clenoliximab Biosimilar, CD4 Monoclonal Antibody
Recombinant Humanized IgG4 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade clenoliximab biosimilar specifically binds to the human CD4.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by clenoliximab.